UK Periodontal Disease Treatment Market (2024-2029)
The UK Periodontal Disease Treatment Market was valued at $91.81 Million in 2024 and projected to reach to $124.38 Million by 2029, representing a compound annual growth rate of 5.2%. The UK periodontal disease treatment market is poised for sustained growth through 2029, driven by demographic shifts, lifestyle factors increasing disease prevalence, and patient education initiatives promoting preventive care.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
UK Periodontal Disease Treatment Market Trends and Insights
- The UK market is driven by increasing prevalence of periodontal disease, rising awareness of oral health, and growing adoption of advanced treatment technologies across dental practices.
- The UK's well-established healthcare infrastructure and emphasis on preventive dentistry support sustained market expansion through the forecast period. In the UK, the periodontal treatment market benefits from strong NHS coverage, private dental sector growth, and patient demand for minimally invasive procedures.
- The UK market is characterized by a mix of traditional scaling and root planing treatments alongside newer laser-based and regenerative therapies.
- By 2029, the UK is expected to see increased investment in periodontal training, digital diagnostics, and specialized periodontal clinics, positioning the country as a mature but growing market within Europe..
Key Market Statistics
- CAGR (2024-2029) 5.2% CAGR
- Market Size, 2024 ~USD 91.81 Million
- Forecast, 2029 ~USD 124.38 Million
- Country UK
UK Periodontal Disease Treatment Market Overview
Market Valuation :
The UK periodontal disease treatment market was valued at £91.81 million in 2024, with projections reaching £124.38 million by 2029, demonstrating steady growth in the dental healthcare sector.
Growth Trajectory :
The UK market is expanding at a CAGR of 5.2%, outpacing broader economic growth and reflecting increased investment in oral health infrastructure and patient demand for periodontal treatments.
Driving Factors :
Rising prevalence of periodontal disease among UK adults, heightened awareness of oral health consequences, and widespread adoption of advanced treatment technologies in NHS and private dental practices are key growth catalysts.
Healthcare Infrastructure :
The UK's well-established healthcare system, including NHS dental services and a robust private sector, provides a stable foundation for market expansion and accessibility of periodontal treatments across regions.
UK Periodontal Disease Treatment Market Dynamics
- NHS reforms and increased funding for dental services are expected to expand treatment accessibility across socioeconomic groups.
- Private dental practices are investing in cutting-edge periodontal technologies, including laser therapy and regenerative procedures, enhancing treatment outcomes and patient satisfaction.
- The market will benefit from growing collaboration between general dentists and periodontists, improving referral pathways and early intervention rates.
- Regulatory support for advanced dental materials and techniques will further accelerate market penetration across the UK..
Related Ecosystem
Dental Devices
- Dental Implants
- Dental Bone Grafts
- Dental Crowns
- Dental Prosthetics
- Zirconium Implants
- DENTSPLY SIRONA Inc.
- Henry Schein, Inc.
- KAVO KERR GROUP
- PLANMECA GROUP
- Patterson Companies, Inc.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- The UK periodontal disease treatment market is valued at £91.81 million in 2024 and will reach £124.38 million by 2029 at a 5.2% CAGR.
- The UK market is supported by NHS funding, private dental sector expansion, and increasing patient awareness of periodontal health.
- Advanced treatment modalities including laser therapy and regenerative procedures are gaining adoption across UK dental practices.
- The UK represents a mature European market with strong regulatory standards and professional training infrastructure driving quality and innovation.
Periodontal Disease Treatment Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | AGGRESSIVE PERIODONTITIS (Disease) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 5.9% from 2024 to 2029 |
| Largest Segment | NON-SURGICAL TREATMENT (Treatment) |
| Market Size Base Year (Billions) | ~USD 2.57 (2024) |
| Revenue Forecast (Billions) | ~USD 3.43 (2029) |
| Segments Covered | Product, Disease, Type, Treatment |
UK Periodontal Disease Treatment Market Report Segmentation
4 segment dimensions are covered across the global market.
By Product
- Consumables
- Equipment
- Medication
By Disease
- Aggressive Periodontitis
- Chronic Periodontitis
- Gingivitis
- Other Diseases
By Type
- Acute Gingivitis
- Chronic Gingivitis
- Medication Therapy
- Recurrent Gingivitis
- Root Planing
- Scaling
By Treatment
- Bone Grafting
- Flap Surgery/Pocket Reduction Therapy
- Guided Tissue Regeneration
- Non-Surgical Treatment
- Other Treatments
- Soft Tissue Graft
Target Audience
- Dental Practice Owners : UK dental practitioners need market data to justify investments in periodontal equipment, plan service expansion, and understand patient demand trends to enhance profitability and clinical outcomes.
- Medical Device Manufacturers : Companies developing periodontal treatment technologies require UK-specific market insights to guide product development, regulatory strategy, and commercial launch planning for the British dental sector.
- Healthcare Investors : Investment firms evaluating opportunities in UK dental healthcare need comprehensive market analysis to assess growth potential, identify acquisition targets, and make informed capital allocation decisions.
- NHS Commissioners : Healthcare commissioners and procurement teams require market intelligence to plan service provision, allocate budgets for periodontal care, and evaluate treatment pathways across UK regions.
- Pharmaceutical and Supply Companies : Suppliers of periodontal materials, pharmaceuticals, and consumables need UK market data to forecast demand, optimize distribution networks, and develop targeted marketing strategies for dental professionals.
Key Companies in the UK Periodontal Disease Treatment Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| DENTSPLY SIRONA | United States | Public Company | Connected Technology Solutions,Essential Dental Solutions,Orthodontic and Implant Solutions, |
| ENVISTA HOLDINGS CORPORATION | United States | Public Company | Specialty Products & Technologies – Implants & Biomaterials,Specialty Products & Technologies – Orthodontics & Clear Aligners,Equipment & Consumables – Imaging, Software & Visualization, |
| HENRY SCHEIN, INC. | United States | Public Company | Global Distribution and Value-Added Services,Global Specialty Products,Global Technology, |
| BIOLASE, INC. | United States | Public Company | Waterlase all-tissue systems,Diode soft-tissue systems,Consumables, fibers, and handpieces, |
| NAKANISHI INC. | Japan | Public Company | Dental handpieces (air turbines, contra-angles, micromotors),Surgical and mobile dentistry systems,Dental lab, hygiene, and maintenance products, |
| A-DEC INC. | Switzerland | Public Company | Flexible placement (temporary staffing and contracting),Permanent placement and career transition,Outsourcing and engineering consulting, |
DENTSPLY SIRONA
DENTSPLY SIRONA is a United States-based public company founded in 1877 with 14,000 employees. The company operates in the dental industry.
ENVISTA HOLDINGS CORPORATION
ENVISTA HOLDINGS CORPORATION is a United States-based public company founded in 2018 with 12,000 employees. The company operates in the dental industry.
HENRY SCHEIN, INC.
HENRY SCHEIN, INC. is a United States-based public company founded in 1932 with 25,000 employees. The company operates in the dental industry.
BIOLASE, INC.
BIOLASE, INC. is a United States-based public company founded in 1984 with 157 employees. The company operates in the dental industry.
NAKANISHI INC.
NAKANISHI INC. is a Japan-based public company founded in 1930 with 2,204 employees. The company operates in the dental industry.
A-DEC INC.
A-DEC INC. is a Switzerland-based public company founded in 1957 with 33,569 employees. The company operates in the dental industry.
Reasons to Buy this Report
- UK-Specific Market Sizing : Access precise valuation data for the UK market (£91.81M in 2024) with detailed forecasts through 2029, enabling accurate budgeting and investment decisions tailored to the British dental market.
- Regional Growth Insights : Understand the 5.2% CAGR specific to the UK, identify regional variations across England, Scotland, Wales, and Northern Ireland, and benchmark performance against global trends at 5.9%.
- NHS and Private Sector Analysis : Gain comprehensive insights into both NHS-funded periodontal services and private practice opportunities, including reimbursement models, funding trends, and patient access patterns unique to the UK healthcare system.
- Competitive Landscape : Identify key players in the UK periodontal market, assess treatment technology adoption rates, and understand competitive positioning among dental practices, suppliers, and healthcare providers.
- Strategic Planning Support : Leverage UK-focused market intelligence to develop targeted expansion strategies, optimize product offerings for British dentists, and capitalize on emerging opportunities in periodontal care delivery.
Frequently asked questions
What is the current size of the UK periodontal disease treatment market?
The UK periodontal disease treatment market was valued at £91.81 million in 2024.
What is the projected market size for the UK by 2029?
The UK periodontal disease treatment market is forecast to reach £124.38 million by 2029.
What is the growth rate of the UK periodontal disease treatment market?
The UK market is expected to grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2029.
What factors are driving growth in the UK periodontal disease treatment market?
Key drivers include rising prevalence of periodontal disease, increased patient awareness, NHS coverage, private sector expansion, and adoption of advanced treatment technologies such as laser therapy and regenerative procedures.
How does the UK market compare to other European markets?
The UK represents a mature European market with strong regulatory standards, established NHS infrastructure, and a robust private dental sector, positioning it as a stable and growing segment within the broader European periodontal treatment market.
RESEARCH METHODOLOGY
Get the Full Periodontal Disease Treatment Market Report
Full forecast, segment splits, and company analysis for all Periodontal Disease Treatment Market.
- US Periodontal Disease Treatment Market
- Canada Periodontal Disease Treatment Market
- Germany Periodontal Disease Treatment Market
- France Periodontal Disease Treatment Market
- Italy Periodontal Disease Treatment Market
- Spain Periodontal Disease Treatment Market
- China Periodontal Disease Treatment Market
- Japan Periodontal Disease Treatment Market
- India Periodontal Disease Treatment Market
- Australia Periodontal Disease Treatment Market
- South Korea Periodontal Disease Treatment Market
- Mexico Periodontal Disease Treatment Market
- Brazil Periodontal Disease Treatment Market
- Argentina Periodontal Disease Treatment Market
- Rest Of Asia Pacific Periodontal Disease Treatment Market
- Rest Of Europe Periodontal Disease Treatment Market
- Rest Of Latin America Periodontal Disease Treatment Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report